MICHELE HOLCOMB, PHD
EVP of Strategy and Corporate Development, Cardinal Health
Dr. Holcomb leads Strategy and Business Development for Cardinal Health across the enterprise, including the pharmaceutical and medical segments. She and her team work closely with the business leaders to define strategies and identify opportunities for growth within the evolving health care landscape. Her team also drives the execution and integration of acquisitions, divestments, and partnerships to support Cardinal Health’s strategic and financial goals.
Holcomb came to Cardinal Health from Teva Pharmaceuticals, where she was the COO of Global R&D and SVP of Strategy, Portfolio, Search, and Partnerships. In this role, she led many aspects of R&D operations, including portfolio management of assets across both the internal R&D pipeline and external opportunities. She also developed approaches for creative partnerships and external pipeline funding. Holcomb originally joined Teva in 2010 as VP of Corporate Strategy, where she led company-wide strategy, including assessment and integration of major acquisitions. She also drove process improvements at key interfaces in R&D, sales & marketing, and supply chain.
Prior to joining Teva, Holcomb was a partner in the Global Pharmaceutical Practice at McKinsey & Company, where she served numerous global pharmaceutical companies and high-growth biotechs. Holcomb is trained as a chemist with a bachelor’s degree from Stanford University, a doctorate from the University of California, Berkeley, and experience as a bench chemist at Syntex Pharmaceuticals and Ciba-Geigy. he also is a member of the board of directors for Bucks County Community College Foundation, and sits on the Editorial Advisory Board of Pharmaceutical Executive.